Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)


Creative Commons License

Wang Y., Minematsu K., Wong K. S. L. , Amarenco P., Albers G. W. , Denison H., ...Daha Fazla

STROKE, cilt.48, ss.167-177, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 48 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1161/strokeaha.116.014891
  • Dergi Adı: STROKE
  • Sayfa Sayıları: ss.167-177

Özet

Background and Purpose-In the SOCRATES trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes), ticagrelor was not superior to aspirin. Because of differences in patient demographics and stroke disease pattern in Asia, outcomes of ticagrelor versus aspirin were assessed among Asian patients in a prespecified exploratory analysis.